IFP Advisors’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History
Bought
Maintained
Sold
IFP Advisors's RSLS Position: Q1 2019 in Review
IFP Advisors sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q1 2019, closing a stake of 5 shares.
IFP Advisors first reported a position in RSLS in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold RSLS as of Q1 2019.
- IFP Advisors reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
- IFP Advisors sold 5 ReShape Lifesciences Inc. Common Stock shares in Q1 2019.
- IFP Advisors first reported a position in ReShape Lifesciences Inc. Common Stock in Q4 2018 and held it in 1 quarter.
- IFP Advisors's ReShape Lifesciences Inc. Common Stock position peaked at $0 in Q4 2018.
- 0 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q1 2019.
Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.